The definition of early axSpA based on expert consensus after going through the Delphi process by ASAS is that the duration of axial symptoms is equal or less than 2 years. Navarro-Compan V, Abst#OP0055 #EULAR2023 @RheumNow https://t.co/5byn0kBEIQ

Dual IL-17A/F inhibition with Bimekizumab reduced MRI inflammatory change in the SIJ and spine in AxSpA, and increasing proportion achieving MRI remission at Wk52, Abst#POS0246 #EULAR2023 @RheumNow https://t.co/w4VkkUklGl

The International Map of AxSpA (IMAS) of >5k patients: delay mean 7.4+/-9 years, 75% active disease, 60% poor mental health, 21% sick leave, 4.6 GP visits before diagnosis, fear=disease progression, hope=relief of pain, IMAS Abst#POS0298 #EULAR2023 @RheumNow https://t.co/wB9Jtbgvy7

Important from @cappelliMD @jhrheumatology irAE cohort on predictors of DMARD requirement in ICI-inflammatory arthritis, and persistent ICI-IA post-ICI cessation. The better we can predict these patients, the more we can get the right therapy early POS0951 #EULAR2023 @RheumNow https://t.co/YGTRl71505

EULAR 2023 recommendations on the management of fatigue in IRMDs. 4 overarching principles and 4 recommendations for monitoring and assessment of fatigue, Dures E Abst#P0370 #EULAR2023 @RheumNow https://t.co/AirPlRLNjZ

The course of symptoms in CSA to RA showed greater severity in the ACPA+ group compared to the ACPA- group. This correlated with MRI-subclinical joint score, suggesting different underlying processes Khidir S Abst#POS319 #EULAR2023 @RheumNow https://t.co/C2ADAkkSM2

Better at Predicting RA from MRI: Humans or Computers? https://t.co/xRVatfiRKS https://t.co/Gwypq8lcdl

• https://bit.ly/3N9PqFu

The future of lupus treatment is oral therapies? There has been an explosion of trials in SLE, including nonrenal and glomerulonephritis studies. @Janetbirdope https://t.co/IQ9bxbTSV4 https://t.co/jVYOphxpAE

• https://bit.ly/3MQhbSh

In an early SpA (DESIR) cohort, the occurrence of a first pregnancy did not seem to increase the number of imaging abnormalities of the SIJ. Overall no significant changes in radiographic and MRI imaging abnormalities of the SIJ, Molto A, Abst#POS0303, #EULAR2023 @RheumNow

Supervised 12 weeks High-intensity interval training program Improves Vo2 peak in IA patients But does not improve pain or fatigue It is disappointing but it is also a small study w/ n=30 pts in each group. It is unclear if the type of exercise has an impact on outcome https://t.co/Plk7sflrh5

What happens when an AI-based symptom checker & an online self-referral tool play Rheumatologists? They don't seem to do great yet! 600 new pts, outw/ 36% dvlpd IA IA Sens 62% Spe 47% Tool Sens 66% Spe 54% More work needed to implement these in practice #EULAR23 @Rheumnow